Walleye Trading
HRTX icon

Walleye Trading’s Heron Therapeutics HRTX Stock Holding History

Walleye Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,000
Closed -$128K – 5551
2021
Q4 		$128K Sell
14,000
-26,800
-66% -$274K ﹤0.01% 4241
2021
Q3 		$436K Buy
40,800
+11,200
+38% +$136K ﹤0.01% 3050
2021
Q2 		$459K Buy
29,600
+28,900
+4,129% +$460K ﹤0.01% 3017
2021
Q1 		$11K Buy
+700
New +$12.5K ﹤0.01% 4627

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Walleye Trading's HRTX Position: Q1 2023 in Review

Walleye Trading sold out of Heron Therapeutics (HRTX) in Q1 2023, closing a stake of 44,600 shares — an estimated $112K sold.

Walleye Trading first reported a position in HRTX in Q3 2015 and held it in 4 quarters. The position peaked at $508K in Q1 2021. 162 funds tracked by Wall St. Rank hold HRTX as of Q1 2023.

  • Walleye Trading reported no remaining Heron Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 44,600 Heron Therapeutics shares in Q1 2023, an estimated $112K.
  • Walleye Trading first reported a position in Heron Therapeutics in Q3 2015 and held it in 4 quarters.
  • Walleye Trading's Heron Therapeutics position peaked at $508K in Q1 2021.
  • 162 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.